ATE520710T1 - Polypeptide von leishmania major und dafür codierende polynukleotide, und deren anwendungen als impfstoffe, therapeutika und diagnostika - Google Patents

Polypeptide von leishmania major und dafür codierende polynukleotide, und deren anwendungen als impfstoffe, therapeutika und diagnostika

Info

Publication number
ATE520710T1
ATE520710T1 AT06724635T AT06724635T ATE520710T1 AT E520710 T1 ATE520710 T1 AT E520710T1 AT 06724635 T AT06724635 T AT 06724635T AT 06724635 T AT06724635 T AT 06724635T AT E520710 T1 ATE520710 T1 AT E520710T1
Authority
AT
Austria
Prior art keywords
polypeptides
applications
vaccines
therapeutics
diagnostics
Prior art date
Application number
AT06724635T
Other languages
English (en)
Inventor
Mehdi Chenik
Sami Lakhal
Hechmi Louzir
Koussay Dellagi
Original Assignee
Pasteur Institut
Pasteur Institut Tunis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002503932A external-priority patent/CA2503932A1/en
Application filed by Pasteur Institut, Pasteur Institut Tunis filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE520710T1 publication Critical patent/ATE520710T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06724635T 2005-04-08 2006-04-07 Polypeptide von leishmania major und dafür codierende polynukleotide, und deren anwendungen als impfstoffe, therapeutika und diagnostika ATE520710T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002503932A CA2503932A1 (en) 2005-04-08 2005-04-08 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
CA002540736A CA2540736A1 (en) 2005-04-08 2006-04-05 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
PCT/EP2006/003978 WO2006108720A2 (en) 2005-04-08 2006-04-07 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof

Publications (1)

Publication Number Publication Date
ATE520710T1 true ATE520710T1 (de) 2011-09-15

Family

ID=36741211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06724635T ATE520710T1 (de) 2005-04-08 2006-04-07 Polypeptide von leishmania major und dafür codierende polynukleotide, und deren anwendungen als impfstoffe, therapeutika und diagnostika

Country Status (8)

Country Link
US (1) US7888492B2 (de)
EP (1) EP1869073B1 (de)
AT (1) ATE520710T1 (de)
BR (1) BRPI0612322A2 (de)
CA (1) CA2540736A1 (de)
IL (2) IL186423A (de)
MX (1) MX2007012515A (de)
WO (1) WO2006108720A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102066411A (zh) * 2008-05-08 2011-05-18 梅里亚有限公司 使用白蛉唾液免疫原的利什曼原虫疫苗
BRPI0915371A2 (pt) 2008-07-04 2016-10-18 Inst Rech Developpement Ird um método para avaliação de proteínas secretadas conservadas
BRPI0804859B1 (pt) * 2008-08-22 2021-11-03 Universidade Federal De Minas Gerais Peptídeos sintéticos para a obtenção de polímero proteíco para imunização contra leishmaniose, produtos e seus usos
BRPI0900961B8 (pt) * 2009-03-23 2021-07-13 Fundacao Oswaldo Cruz métodos e kit para diagnóstico de leishmaniose
SA110310855B1 (ar) * 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
BRPI1006646A2 (pt) * 2010-08-13 2012-04-17 Univ Minas Gerais composição imunogênica para vacina e kit para teste imunodiagnóstico de leishmaniose visceral
US20160158329A1 (en) * 2013-03-28 2016-06-09 Infectious Disease Research Institute Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826018B1 (fr) * 2001-06-18 2005-01-07 Pasteur Institut Tunis Gene associe a la virulence du parasite leishmania

Also Published As

Publication number Publication date
WO2006108720A3 (en) 2007-03-08
EP1869073A2 (de) 2007-12-26
MX2007012515A (es) 2008-04-11
US7888492B2 (en) 2011-02-15
IL212653A (en) 2015-02-26
HK1115599A1 (en) 2008-12-05
IL186423A (en) 2015-02-26
BRPI0612322A2 (pt) 2010-11-03
US20090169554A1 (en) 2009-07-02
IL212653A0 (en) 2011-07-31
WO2006108720A2 (en) 2006-10-19
CA2540736A1 (en) 2006-10-08
IL186423A0 (en) 2008-01-20
EP1869073B1 (de) 2011-08-17

Similar Documents

Publication Publication Date Title
CY1112655T1 (el) Γλυκοζυλιωμενη ιl-7, παρασκευη και χρησεις
DE60330923D1 (de) Menschliche Koagulationsfaktor VII Polypeptide
UA113609C2 (xx) Антигензв'язуючий білок, який зв'язує людський il-23
DK2157192T3 (da) Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner)
IL212653A0 (en) Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
DK1767546T3 (da) Angiogenese-inhiberende kimært protein og dets anvendelse
ATE509953T1 (de) Antikörper gegen den erythropoietinrezeptor und verwendungen davon
ATE512980T1 (de) Polypeptide mit beta-glucosidase-aktivität sowie diese codierende polynukleotide
SG10201408073XA (en) Muteins of human lipocalin 2 (lcn2, hngal) with affinity for a given target
ATE556092T1 (de) Mittel zur diagnose und therapie von ctcl
ATE209684T1 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
WO2004093804A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
ATE395602T1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
EA200501711A1 (ru) Семейство секретируемых белков
ATE470478T1 (de) An ovarialkrebs beteiligtes protein
DE60143561D1 (de) Nukleinsäuren kodierend für polypeptide mit chips aktivität
ATE368687T1 (de) Thrombopoietinproteine mit verbesserten eigenschaften
DK1641926T3 (da) Terapeutisk anvendelse af LPI, en stafylokokal lectinstiinhibitor ved inflammatoriske sygdomme
DE60120507D1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
IL169256A (en) Polypeptide having metalloprotease activity, nucleic acid encoding it and pharmaceutical composition comprising it
ATE428713T1 (de) Beta-strang-mimetika
ATE527343T1 (de) Nucleinsäuresequenz und protein sowie polypeptide kodierend für mannit-dehydrogenasen oder deren teile sowie deren herstellung und verwendung in diagnostik und therapie
WO2004094598A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
ATE397753T1 (de) Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties